Next Generation CAR-NK cell Therapy Leverages Alloimmune Defense Technology to Persist Without Conditioning Chemotherapy for the Treatment of Autoimmune Disease
Thursday, July 10, 2025 1 min read
Key Takeaway: The article discusses a next-generation CAR-NK cell therapy that utilizes alloimmune defense technology. This innovative approach aims to treat autoimmune diseases without the need for conditioning chemotherapy. The therapy's potential benefits and mechanisms are highlighted, but specific details on clinical outcomes or trials are not provided.
Price reaction · baseline $1.155 (2025-07-10T15:14:00.000Z) · hit during market hours · 1 other FATE headline(s) in the window, move may be shared
day 0 close · peak
+0.4%
Market Sentiment Analysis
Full Press Release Details
• Privacy Overview
• Strictly Necessary Cookies
• 3rd Party Cookies
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
For more information about the data we collect please visit our Privacy Policy .
Strictly Necessary Cookies is enabled at all times so that we can save your preferences for cookie settings.
This website uses Google Analytics to collect information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.